To compare and evaluate the effect of topical Cyclosporine A eye drops and topical Interferon alpha 2b eye drops in preventing recurrence of pterygium following primary pterygium excision and limbal conjunctival autograft surgery

COMPARATIVE EVALUATION OF TOPICAL CYCLOSPORINE A AND TOPICAL INTERFERON ALPHA 2B AS AN ADJUNCT TO LIMBAL CONJUNCTIVAL AUTOGRAFT IN PTERYGIUM SURGERY

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/04/024498

Enrollment

Registered

2020-04-07

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye

Interventions

Intervention1: Topical Cyclosporine A 0.05 %four times daily: Evaluation of Topical Cyclosporine A as an adjunct to Limbal conjunctival autograft in pterygium surgery Intervention2: Topical interfero

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH PROGRESSIVE PTERYGIUM,HEAD OF PTERYGIUM ENCROACHING UPON THE PERIPHERAL CORNEA

Exclusion criteria

Exclusion criteria: 1.RECURRENT PTERYGIUM 2.OCULAR SURFACE DISORDER INCLUDING DRY EYES AND MEIBOMIAN GLAND DYSFUNCTION 3.ANY EXTRAOCULAR SURGERY PAST 6 MONTHS 4.PREGNANT WOMEN 5.UNCONTROLLED SYSTEMIC DISEASES

Design outcomes

Primary

Measure	Time frame
RECURRENCE OF PTERYGIUMTimepoint: THREE MONTHS	—

Secondary

Measure	Time frame
COMPLICATIONS- LIKE SCLERAL MELTING, CORNEAL OPACIFICATION ETC.Timepoint: THREE MONTHS	—

Countries

India

Contacts

Public ContactDR BANU PAVITRA K

MAULANA AZAD MEDICAL COLLEGE

rainausha@hotmail.com9818902220

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026